Clinical Trials Browser

Small Cell Lung Carcinoma

Neuroblastoma, Ganglioneuroblastoma

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

ENSAT Stage I Adrenal Cortex Carcinoma

Lung Neoplasms

Small Cell Lung Carcinoma

Stage I Mixed Cell Type Kidney Wilms Tumor

Leukemia, Myeloid, Acute

Lung Neoplasms, Small Cell Lung Carcinoma

Lymphoma, Non-Hodgkin

Down Syndrome, Leukemia, Myeloid, Acute

Neoplasms, Germ Cell and Embryonal

Radiation Injuries, Disease Progression

Childhood Renal Tumor

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Multiple Myeloma

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Retinoblastoma

Neuroblastoma

Clinical Trials

DeLLphi-312

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

OLYMPIA-4

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

AML-DS-2025

P3BEP

Omitting CTV for Primary Tumor in LS-SCLC

RANDOMET

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

HL-Russia-1

Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

MOGCT-01

SCST-01

Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)